The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-015-5084-0
Published Online: 2016-01-26
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Bok-Soon
Kim, Haeng-Jun
Hwang, Jae-Woong
Cheong, Kwang Ho
Kim, Kyung-Ah
Cha, Hyun-Young
Lee, Ji Min
Kim, Chul-Ho
Text and Data Mining valid from 2016-01-26